Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital.

Chatterjee K, Coshic P, Borgohain M, Premchand, Thapliyal RM, Chakroborty S, Sunder S.

Natl Med J India. 2012 Jul-Aug;25(4):207-9.

PMID:
23278777
2.

Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India.

Agarwal N, Chatterjee K, Coshic P, Borgohain M.

Transfus Apher Sci. 2013 Dec;49(3):482-4. doi: 10.1016/j.transci.2013.03.004. Epub 2013 Mar 28.

PMID:
23541414
3.

Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.

Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.

Transfusion. 2007 Oct;47(10):1803-8.

PMID:
17880604
4.

Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.

Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR; SIMTI Research Group.

Transfusion. 2008 Oct;48(10):2205-13. doi: 10.1111/j.1537-2995.2008.01813.x. Epub 2008 Jul 8.

PMID:
18631163
5.

Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.

Yang Z, Xu L, Liu L, Feng Q, Zhang L, Ma W, Saldanha J, Wang M, Zhao L.

Transfusion. 2013 Oct;53(10 Pt 2):2538-44. doi: 10.1111/trf.12159. Epub 2013 Mar 11.

PMID:
23480568
6.

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.

Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, Yamanaka R, Yoshikawa A, Nishioka K; Japanese Red Cross NAT Research Group.

J Virol Methods. 2003 Sep;112(1-2):145-51.

PMID:
12951223
7.

Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.

Nübling CM, Unkelbach U, Chudy M, Seitz R.

Transfusion. 2008 May;48(5):822-6. doi: 10.1111/j.1537-2995.2007.01612.x. Epub 2008 Jan 15.

PMID:
18208414
8.

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.

Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.

Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.

PMID:
19309474
10.

Comparative analysis of triplex nucleic acid test assays in United States blood donors.

Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Dodd RY, Kleinman SH.

Transfusion. 2013 Oct;53(10 Pt 2):2525-37. doi: 10.1111/trf.12178. Epub 2013 Apr 3.

11.

Performance of the serologic and molecular screening of blood donations for the hepatitis B and C viruses in a Mexican Transfusion Center.

Chiquete E, Sánchez LV, Becerra G, Quintero A, Maldonado M, Panduro A.

Ann Hepatol. 2005 Oct-Dec;4(4):275-8.

PMID:
16432494
12.

Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.

Grabarczyk P, van Drimmelen H, Kopacz A, Gdowska J, Liszewski G, Piotrowski D, Górska J, Kuśmierczyk J, Candotti D, Lętowska M, Lelie N, Brojer E.

Transfusion. 2013 Oct;53(10 Pt 2):2512-24. doi: 10.1111/trf.12190. Epub 2013 Apr 17.

PMID:
23590145
13.

Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.

Al Shaer L, AbdulRahman M, John TJ, AlHashimi A.

Transfusion. 2012 Nov;52(11):2300-9. doi: 10.1111/j.1537-2995.2012.03740.x. Epub 2012 Jun 13.

PMID:
22691239
14.

The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.

Ohnuma H, Tanaka T, Yoshikawa A, Murokawa H, Minegishi K, Yamanaka R, Lizuka HY, Miyamoto M, Satoh S, Nakahira S, Tomono T, Murozuka T, Takeda Y, Doi Y, Mine H, Yokoyama S, Hirose T, Nishioka K; Japanese Red Cross NAT Screening Research Group.

Microbiol Immunol. 2001;45(9):667-72.

15.

Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.

Japanese Red Cross NAT Screening Research Group.

Jpn J Infect Dis. 2000 Jun;53(3):116-23. Erratum in: Jpn J Infect Dis 2000 Oct;53(5):219.

PMID:
10957709
16.

[Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].

Contreras AM, Reta CB, Torres O, Celis A, Domínguez J.

Salud Publica Mex. 2011;53 Suppl 1:S13-8. Spanish.

17.

Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.

Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR.

Transfus Apher Sci. 2009 Aug;41(1):3-7. doi: 10.1016/j.transci.2009.05.001. Epub 2009 May 31.

PMID:
19487161
18.

Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.

Makroo RN, Choudhury N, Jagannathan L, Parihar-Malhotra M, Raina V, Chaudhary RK, Marwaha N, Bhatia NK, Ganguly AK.

Indian J Med Res. 2008 Feb;127(2):140-7.

PMID:
18403791
19.

Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.

McCormick MK, Dockter J, Linnen JM, Kolk D, Wu Y, Giachetti C.

J Clin Virol. 2006 Jul;36(3):166-76. Epub 2006 Jan 20.

PMID:
16427802
20.

Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan.

Moiz B, Moatter T, Shaikh U, Adil S, Ali N, Mahar F, Shamsuddin N, Khurshid M.

Transfusion. 2014 Jun;54(6):1652-9. doi: 10.1111/trf.12521. Epub 2014 Jan 3.

PMID:
24383918

Supplemental Content

Support Center